192
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet

&
Pages 825-836 | Received 10 May 2011, Accepted 02 Oct 2011, Published online: 17 Nov 2011

References

  • Hahm H, Augsburger L. (2008). Orally disintegration tablets and related tablet formulations. In: Augsburger L, Hoag S, eds. Pharmaceutical Dosage Forms: Tablets, vol. 2: Rational Design and Formulation, 3rd edition. New York: Informa Healthcare USA, Inc, 293–311.
  • Fu Y, Yang S, Jeong SH, Kimura S, Park K. (2004). Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug Carrier Syst, 21:433–476.
  • McLaughlin R, Banbury S, Crowley K. (2009). Orally disintegrating tablets: the effect of recent FDA guidance on ODT technologies and applications. Pharm Technol, 33:S18–S25.
  • Corveleyn S, Remon JP. (1997). Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug. Int J Pharm, 152:215–225.
  • Corveleyn S, Remon JP. (1999). Stability of freeze-dried tablets at different relative humidities. Drug Dev Ind Pharm, 25:1005–1013.
  • Inactive Ingredient Search for Approved Drug Products, U.S. Food and Drug Administration. (2010). Available at: http://www.accessdata.fda.gov/scripts/cder/iig/. Accessed on 28 April 2011.
  • Sullivan E. (1998). Disintegrant composition for dispersible solids. International Patent Application. PCT/US97/12183. FMC Corp.
  • Kothari S, Desai S. (2006). Flash-melt oral dosage formulation. European Patent. EP1145711B1. Bristol-Myers Squibb Co.
  • Caramella C, Colombo P, Conte U, Ferrari F, Gazzaniga A, La Manna A, et al. (1988). A physical analysis of the phenomenon of tablet disintegration. Int J Pharm, 44:177–186.
  • USP 24-NF 19. (2000). Rockville: The United States Pharmacopeial Convention.
  • Adolfsson A, Gustafsson C, Nyström C. (1999). Use of tablet tensile strength adjusted for surface area and mean interparticulate distance to evaluate dominating bonding mechanisms. Drug Dev Ind Pharm, 25:753–764.
  • Bond M. (2009). Xylitol. In: Rowe R, Shesky P, Quinn M, eds. Pharmaceutical Excipients, 6th Edition. London and Washington D.C.: American Pharmaceutical Association and Pharmaceutical Press, 786–789.
  • Colombo P, Ferrari F, Gazzaniga A, Caramella C, Conte U, La Manna A, et al. (1988). Simulation of the disintegration process of pharmaceutical tablets. Pharm Acta Helv, 63:221–223.
  • Brzeczko AW. (1989). Ph.D. Dissertation: A critical evaluation of tablet disintegration processes. Baltimore: University of Maryland Baltimore.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.